Skip to content

Patient-controlled analgesia with esketamine reduces rebound pain after surgery for patients receiving peripheral nerve blockade

Patient-controlled analgesia with esketamine reduces rebound pain after surgery for patients receiving peripheral nerve blockade

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096660
Enrollment
Unknown
Registered
2025-01-27
Start date
2024-05-22
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rebound pain

Interventions

Esketamine(ES):Total volume of patient-controlled analgesia pump: 100ml (esketamine 1.25mg/kg + sufentanil 100ug + flurbiprofen axetil 100mg), background infusion rate: 2 ml/h, single dose: 2 ml, lock
Routine patient-controlled analgesia (PL):Total volume of patient-controlled analgesia pump: 100ml (e sufentanil 100ug + flurbiprofen axetil 100mg), background infusion rate: 2 ml/h, single dose: 2 ml

Sponsors

Ganzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 75 who undergo unilateral shoulder arthroscopy surgery; 2. 18<= BMI <=30 kg/m^2; 3. ASA grades I-III; 4. Informed consent of the patient or her family members

Exclusion criteria

Exclusion criteria: 1. Contraindications to nerve block (preoperative nerve damage involving the surgical site, diabetes mellitus with peripheral neuropathy symptoms, bleeding or abnormal coagulation function, local or systemic infection); 2. Patients who take sedative and analgesic drugs or steroid drugs for a long time; 3. Patients with a history of neurological, psychiatric, or neuromuscular diseases; 4. Previous history of ipsilateral shoulder surgery; 5. Patients with a known allergy or contraindication to ropivacaine or esketamine and chronic analgesics; 6. Patients with a clear diagnosis of lung disease (chronic bronchitis, COPD, pulmonary bullae, pulmonary embolism, lung cancer, etc.); 7. Patients with severe cardiac disease (cardiac function grade III); 8. Hypertensive patients with poor blood pressure control (perioperative blood pressure: 180 / 100mmHg); 9. Patients who cannot complete the preoperative scale

Design outcomes

Primary

MeasureTime frame
The incidence of rebound pain;

Secondary

MeasureTime frame
Time of onset, duration and intensity of rebound pain;time to the first analgesic request;Postoperative analgesic consumption;Rebound pain score;QoR-15 score;Adverse reactions;Quality of sleep;Pain scores at scheduled time points;

Countries

China

Contacts

Public ContactLanhua Zhong

Ganzhou People's Hospital

1619321845@qq.com+86 183 6960 8967

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026